Log In
Sunday 18th March 2018

The jab that fights some cancers

24th October 2008

Scientists have carried out tests to find out if the TroVax injection can help patients to fight some common cancers.

The vaccine was developed by a team at Oxford BioMedica and was shown to extend the lives of bowel cancer patients by an average of 15 months. Dr Richard Harrop of Oxford BioMedica, said: "Our exploratory analysis of data from nine different trials of TroVax demonstrate significant associations between immune responses and overall survival in patients with colorectal (bowel) cancer, renal (kidney) cancer and prostate cancer. In addition, the data show the vaccine is well tolerated by patients."


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2018